Emergency medicine leadership in industry-sponsored clinical trials

Craig Newgard, Sunghye Kim, Carlos A. Camargo

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Objective: To identify and characterize emergency medicine (EM) researchers who, since 1990, have served on a steering committee (SC) or as overall principal investigator (PI) of an industry-sponsored, multicenter clinical trial involving a pharmaceutical or device. Methods: North American EM research directors (RDs) and other prominent EM investigators (for those hospitals without a RD) were identified from eight sources, including the Society for Academic Emergency Medicine RD Interest Group and the Multicenter Airway Research Collaboration (MARC) database. The identified investigators were sent a screening survey requesting information regarding industry-sponsored clinical research at their site. The individual EM investigators identified by this screening survey were then interviewed by telephone (validation survey) to further explore their leadership experience in industry-sponsored clinical trials. Results: Of 153 identified RDs and prominent EM researchers, 138 responded to the screening survey (90% response rate). Eighty-five EM investigators reportedly had served on a SC or as overall PI for an industry-sponsored clinical trial. Of these 85 North American EM investigators, 77 were available for a structured telephone interview (91% response rate). Although 41 (53%) of the investigators confirmed their leadership role, 36 (47%) had not served in either role. Among the 41 confirmed investigators, 19 (25%) had served as a SC member, 10 (13%) had served as overall PI, and 12 (16%) had experience in both roles. Individual responses provided suggestions for pursuing such leadership positions. Conclusions: These data suggest the opportunity to expand EM leadership in industry-sponsored clinical trials and demonstrate the need for validation of reports obtained by a departmental research contact. The suggestions from EM researchers who have attained these leadership roles may provide strategies for investigators interested in pursuing these positions.

Original languageEnglish (US)
Pages (from-to)169-174
Number of pages6
JournalAcademic Emergency Medicine
Volume10
Issue number2
DOIs
StatePublished - Feb 1 2003

Fingerprint

Emergency Medicine
Industry
Research Personnel
Clinical Trials
Research
Committee Membership
Public Opinion
Telephone
Multicenter Studies

Keywords

  • Clinical trials
  • Emergency medicine
  • Industry-sponsored trials
  • Leadership

ASJC Scopus subject areas

  • Emergency Medicine

Cite this

Emergency medicine leadership in industry-sponsored clinical trials. / Newgard, Craig; Kim, Sunghye; Camargo, Carlos A.

In: Academic Emergency Medicine, Vol. 10, No. 2, 01.02.2003, p. 169-174.

Research output: Contribution to journalArticle

Newgard, Craig ; Kim, Sunghye ; Camargo, Carlos A. / Emergency medicine leadership in industry-sponsored clinical trials. In: Academic Emergency Medicine. 2003 ; Vol. 10, No. 2. pp. 169-174.
@article{bd6e344bf63342539dcf90e6dc1a50da,
title = "Emergency medicine leadership in industry-sponsored clinical trials",
abstract = "Objective: To identify and characterize emergency medicine (EM) researchers who, since 1990, have served on a steering committee (SC) or as overall principal investigator (PI) of an industry-sponsored, multicenter clinical trial involving a pharmaceutical or device. Methods: North American EM research directors (RDs) and other prominent EM investigators (for those hospitals without a RD) were identified from eight sources, including the Society for Academic Emergency Medicine RD Interest Group and the Multicenter Airway Research Collaboration (MARC) database. The identified investigators were sent a screening survey requesting information regarding industry-sponsored clinical research at their site. The individual EM investigators identified by this screening survey were then interviewed by telephone (validation survey) to further explore their leadership experience in industry-sponsored clinical trials. Results: Of 153 identified RDs and prominent EM researchers, 138 responded to the screening survey (90{\%} response rate). Eighty-five EM investigators reportedly had served on a SC or as overall PI for an industry-sponsored clinical trial. Of these 85 North American EM investigators, 77 were available for a structured telephone interview (91{\%} response rate). Although 41 (53{\%}) of the investigators confirmed their leadership role, 36 (47{\%}) had not served in either role. Among the 41 confirmed investigators, 19 (25{\%}) had served as a SC member, 10 (13{\%}) had served as overall PI, and 12 (16{\%}) had experience in both roles. Individual responses provided suggestions for pursuing such leadership positions. Conclusions: These data suggest the opportunity to expand EM leadership in industry-sponsored clinical trials and demonstrate the need for validation of reports obtained by a departmental research contact. The suggestions from EM researchers who have attained these leadership roles may provide strategies for investigators interested in pursuing these positions.",
keywords = "Clinical trials, Emergency medicine, Industry-sponsored trials, Leadership",
author = "Craig Newgard and Sunghye Kim and Camargo, {Carlos A.}",
year = "2003",
month = "2",
day = "1",
doi = "10.1197/aemj.10.2.169",
language = "English (US)",
volume = "10",
pages = "169--174",
journal = "Academic Emergency Medicine",
issn = "1069-6563",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Emergency medicine leadership in industry-sponsored clinical trials

AU - Newgard, Craig

AU - Kim, Sunghye

AU - Camargo, Carlos A.

PY - 2003/2/1

Y1 - 2003/2/1

N2 - Objective: To identify and characterize emergency medicine (EM) researchers who, since 1990, have served on a steering committee (SC) or as overall principal investigator (PI) of an industry-sponsored, multicenter clinical trial involving a pharmaceutical or device. Methods: North American EM research directors (RDs) and other prominent EM investigators (for those hospitals without a RD) were identified from eight sources, including the Society for Academic Emergency Medicine RD Interest Group and the Multicenter Airway Research Collaboration (MARC) database. The identified investigators were sent a screening survey requesting information regarding industry-sponsored clinical research at their site. The individual EM investigators identified by this screening survey were then interviewed by telephone (validation survey) to further explore their leadership experience in industry-sponsored clinical trials. Results: Of 153 identified RDs and prominent EM researchers, 138 responded to the screening survey (90% response rate). Eighty-five EM investigators reportedly had served on a SC or as overall PI for an industry-sponsored clinical trial. Of these 85 North American EM investigators, 77 were available for a structured telephone interview (91% response rate). Although 41 (53%) of the investigators confirmed their leadership role, 36 (47%) had not served in either role. Among the 41 confirmed investigators, 19 (25%) had served as a SC member, 10 (13%) had served as overall PI, and 12 (16%) had experience in both roles. Individual responses provided suggestions for pursuing such leadership positions. Conclusions: These data suggest the opportunity to expand EM leadership in industry-sponsored clinical trials and demonstrate the need for validation of reports obtained by a departmental research contact. The suggestions from EM researchers who have attained these leadership roles may provide strategies for investigators interested in pursuing these positions.

AB - Objective: To identify and characterize emergency medicine (EM) researchers who, since 1990, have served on a steering committee (SC) or as overall principal investigator (PI) of an industry-sponsored, multicenter clinical trial involving a pharmaceutical or device. Methods: North American EM research directors (RDs) and other prominent EM investigators (for those hospitals without a RD) were identified from eight sources, including the Society for Academic Emergency Medicine RD Interest Group and the Multicenter Airway Research Collaboration (MARC) database. The identified investigators were sent a screening survey requesting information regarding industry-sponsored clinical research at their site. The individual EM investigators identified by this screening survey were then interviewed by telephone (validation survey) to further explore their leadership experience in industry-sponsored clinical trials. Results: Of 153 identified RDs and prominent EM researchers, 138 responded to the screening survey (90% response rate). Eighty-five EM investigators reportedly had served on a SC or as overall PI for an industry-sponsored clinical trial. Of these 85 North American EM investigators, 77 were available for a structured telephone interview (91% response rate). Although 41 (53%) of the investigators confirmed their leadership role, 36 (47%) had not served in either role. Among the 41 confirmed investigators, 19 (25%) had served as a SC member, 10 (13%) had served as overall PI, and 12 (16%) had experience in both roles. Individual responses provided suggestions for pursuing such leadership positions. Conclusions: These data suggest the opportunity to expand EM leadership in industry-sponsored clinical trials and demonstrate the need for validation of reports obtained by a departmental research contact. The suggestions from EM researchers who have attained these leadership roles may provide strategies for investigators interested in pursuing these positions.

KW - Clinical trials

KW - Emergency medicine

KW - Industry-sponsored trials

KW - Leadership

UR - http://www.scopus.com/inward/record.url?scp=0037328623&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037328623&partnerID=8YFLogxK

U2 - 10.1197/aemj.10.2.169

DO - 10.1197/aemj.10.2.169

M3 - Article

C2 - 12574016

AN - SCOPUS:0037328623

VL - 10

SP - 169

EP - 174

JO - Academic Emergency Medicine

JF - Academic Emergency Medicine

SN - 1069-6563

IS - 2

ER -